Showing 81-90 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount | 
|---|---|---|---|---|---|
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-April-2026 | $799,998.91 | 
| Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances | University of California, San Diego | Schafer Boeder | Improving Lives | 01-July-2022 to 30-June-2027 | $749,956.58 | 
| Pancreatic Lymph Node T cell Composition and Function in Human Type 1 Diabetes | Trustees of the University of Pennsylvania | Gregory Golden | Cures | 01-April-2023 to 31-March-2026 | $214,356.00 | 
| Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs | Trustees of the University of Pennsylvania | Ji Lei | Cures | 01-June-2025 to 31-May-2027 | $749,999.08 | 
| An AI-driven bioelectronics system to accelerate SC-islet maturation | Trustees of the University of Pennsylvania | Juan Alvarez | Cures | 01-April-2025 to 31-March-2026 | $200,000.00 | 
| T1 TRIDENT / Transformative Research in Diabetic Nephropathy | Trustees of the University of Pennsylvania | Katalin Susztak | Improving Lives | 01-September-2019 to 30-September-2024 | $191,795.06 | 
| Mapping islet-reactive T cell responses by islet cell co-culture | Trustees of the University of Pennsylvania | Michael Betts | Cures | 01-July-2022 to 30-June-2025 | $825,000.00 | 
| Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy | Trustees of the University of Pennsylvania | Michael Betts | Cures | 01-September-2024 to 31-August-2027 | $900,000.00 | 
| Targeting self-RNA sensing as a trigger of inflammation in type 1 diabetes | Trustees of the University of Pennsylvania | Qin Li | Cures | 01-April-2025 to 31-March-2026 | $199,919.54 | 
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 30-September-2026 | $560,000.00 |